Agency Information Collection Activities: Proposed Collection; Comment Request, 4041-4043 [2012-1398]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 17 / Thursday, January 26, 2012 / Notices
Dated: January 17, 2012.
Carolyn M. Clancy,
Director.
Proposed Project
[FR Doc. 2012–1400 Filed 1–25–12; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, HHS.
AGENCY:
ACTION:
Notice.
This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project:
‘‘Assessing the Feasibility of
Disseminating Effective Health Care
Products through a Shared Electronic
Medical Record Serving Member
Organization of a Health Information
Exchange.’’ In accordance with the
Paperwork Reduction Act, 44 U.S.C.
3501–3521, AHRQ invites the public to
comment on this proposed information
collection.
This proposed information collection
was previously published in the Federal
Register on November 15th, 2011 and
allowed 60 days for public comment. No
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment.
SUMMARY:
Comments on this notice must be
received by February 27, 2012.
DATES:
Written comments should
be submitted to: AHRQ’s OMB Desk
Officer by fax at (202) 395–6974
(attention: AHRQ’s desk officer) or by
email at
OIRA_submission@omb.eop.gov
(attention: AHRQ’s desk officer).
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
mstockstill on DSK4VPTVN1PROD with NOTICES
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
VerDate Mar<15>2010
17:14 Jan 25, 2012
Jkt 226001
Assessing the Feasibility of
Disseminating Effective Health Care
Products through a Shared Electronic
Medical Record Serving Member
Organization of a Health Information
Exchange
The Agency for Healthcare Research
and Quality (AHRQ) requests that the
Office of Management and Budget
(OMB) approve under the Paperwork
Reduction Act of 1995 this collection of
information from users of work products
and services initiated by the John M.
Eisenberg Clinical Decisions and
Communications Science Center
(Eisenberg Center).
AHRQ is the lead agency charged
with supporting research designed to
improve the quality of healthcare,
reduce its cost, improve patient safety,
decrease medical errors, and broaden
access to essential services. AHRQ’s
Eisenberg Center’s mission is improving
communication of findings to a variety
of audiences (‘‘customers’’), including
consumers, clinicians, and health care
policy makers. The Eisenberg Center
compiles research results into useful
formats for customer stakeholders. The
Eisenberg Center also conducts
investigations into effective
communication of research findings in
order to improve the usability and rapid
incorporation of findings into medical
practice. The Eisenberg Center is one of
three components of AHRQ’s Effective
Health Care (EHC) Program. The
collections proposed under this
clearance include activities to assess the
feasibility of disseminating materials
developed by the Eisenberg Center
through the use of an electronic medical
record (EMR) shared by a network of
clinical care providers that are part of a
Health Information Exchange (HIE)
operating in multiple sites in several
states. Our Community Health
Information Network (OCHIN) members
include 30 clinical care organizations
operating more than 230 primary care
clinics in six states. Data will be
gathered from three different OCHINmember organizations representing a
total of 10 primary care clinics. The
information generated will be provided
to AHRQ to guide decision making and
planning for additional efforts to foster
EHC Program product distribution via
EMR prompting and product linkages.
This research has the following goals:
(1) Identify facilitators and barriers to
successful efforts to implement
processes that: (a) Support use of EHC
Program products by clinicians in
practice, and (b) place relevant clinical
information in the hands of patients and
family members in languages and
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
4041
formats that are appropriate to patients’
information needs;
(2) Examine ways in which EHC
Program products can be used in
concert with other support programs
and products (e.g., healthwise®
resources available through the EMR;
brief patient instructions and letters,
including those designed for use with
persons having very low literacy skills);
(3) Assess the extent to which EHC
Program products are used (e.g.,
accessed by clinicians, provided to
patients in relevant formats) in settings
where use is supported by automated
EMR features, such as on-screen
prompts and reminders; and
(4) Document the perceived value of
integrating EHC Program products into
systems of care supported by an EMR
system as self-reported by clinicians
involved in direct care of patients and
clinic support personnel who interact
with patients.
This study is being conducted by
AHRQ through its contractor, the
Eisenberg Center—Baylor College of
Medicine, pursuant to AHRQ’s statutory
authority to conduct and support
research, and disseminate information,
on healthcare and on systems for the
delivery of such care, including
activities with respect to the quality,
effectiveness, efficiency,
appropriateness and value of healthcare
services and clinical practice. 42 U.S.C.
299a(a)(1) and (4).
Method of Collection
To achieve the goals of this project the
following data collections will be
implemented:
(1) Automated Data Capture from
EMR Usage Logs. Electronic usage data
will be collected to determine the extent
to which EHC Program guides for
clinicians and patients were accessed to
support shared decision making and
patient education. The data will be
retrieved from the existing EMR-linked
database operated by the Kaiser
Permanente staff in their coordination of
activities related to the OCHIN HIE.
Data will include: (a) Number and
frequency of retrieval of EHC resource
materials; (b) specific types of materials
retrieved; and (c) health topic or
condition targeted in the EHC materials.
These data will inform the development
of follow-up questions to be
administered to clinicians and patients
in the interviews and surveys described
below. Because the data will be
obtained using automated systems
already in place, no special effort will
be needed to generate these data, and
thus this task is not included in the
burden estimates in Exhibits 1 and 2.
E:\FR\FM\26JAN1.SGM
26JAN1
4042
Federal Register / Vol. 77, No. 17 / Thursday, January 26, 2012 / Notices
(2) Interviews with Clinicians.
Interviews will be held with clinical
service providers for the following
purposes: (a) Obtain perceptions of the
overall value, relevancy, currency and
appropriateness of EHC Program
products in addressing the health
service needs of patients treated in
clinical settings; (b) assess ease of use of
the materials in terms of access via the
EMR; (c) determine perceived success of
efforts to employ EHC Program products
and related materials in addressing the
needs of patients with limited language
skills and/or low literacy levels; and (d)
describe the relative success of efforts to
use the EHC Program products in
concert with other tools (e.g.,
healthwise® resources) in promoting
patient engagement in their own health
care or in the care of family members.
(3) Interviews with Support Staff.
Interviews will be held with nonclinical support staff to characterize
perceptions of how the introduction of
EHC Program products: (a) Affected
clinic workflows and influenced the
work that staff was required to do in
supporting clinician-patient
interactions; and (b) facilitated or
impeded efforts to inform patients about
actions they could take in being more
fully involved in their own health care.
(4) Interviews with Patients.
Interviews will be held with recruited
patients to determine if they: (a) Viewed
the EHC Program products that they
were provided as useful to them in
understanding their health issues; (b)
were able to understand the EHC
Program-related information that was
provided to them sufficiently to take
actions in their own health care; and (c)
have suggestions about how the EHC
Program materials could be changed or
the delivery of them done in a different
way to make the materials more useful
and/or accessible to patients.
(5) Survey of Clinicians. A
questionnaire will be administered to
clinical care providers near the end of
the study to gather quantitative data
around their assessments of: (a) The
relevancy of the EHC Program materials
to the patients they serve; (b) the
appropriateness of the products in
addressing specific clinical issues; (c)
the ease of use of the system created to
provide access to EHC Program products
through the EMR; and (d) overall ratings
of the approach in addressing patient
needs with regard to specific conditions
addressed by the products available.
The interviews with clinicians,
clinical staff, and patients will be
conducted throughout the project
period, approximately every three
months with different sets of
participants, to inform and refine
delivery mechanisms and monitor
progress.
This information will be used to
determine the feasibility of: (a)
Mounting broader efforts to distribute
clinician and consumer guides, as well
as other EHC products using EMRs as
the primary vehicle for providing
product access at the point of care; and
(b) initiating additional studies to
identify factors that encourage or deter
effective integration of EHC products
into care processes using electronic
tools and care delivery support systems,
like the EMR, that are increasingly
common in clinical work settings.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated
annualized burden for the respondents’
time to participate in this research.
Three rounds of interviews will be
conducted during the project period
(each round of interviews to be held
approximately every three months with
separate sets of participants) to assess
progress and adjust methods or refine
materials as needed. Interviews will be
conducted with 100 patients, 50
clinicians and 50 clinical support staff.
Each interview is estimated to last no
more than 30 minutes. All clinicians in
each participating clinic will have
access to the EMR and will be invited
to participate in an online
questionnaire. Approximately 200
clinicians will complete the 10-minute
questionnaire.
Exhibit 2 shows the estimated
annualized cost burden associated with
the respondents’ time to participate in
this research. The total annual cost
burden is estimated to be $6,274.
EXHIBIT 1—ESTIMATED ANNUALIZED TOTAL BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Type of data collection
Hours per
response
Total burden
hours
Interviews with Clinicians .................................................................
Interviews with Support Staff ...........................................................
Interviews with Patients ...................................................................
Survey of Clinicians .........................................................................
50
50
100
200
1
1
1
1
30/60
30/60
30/60
10/60
25
25
50
33
Total ..........................................................................................
400
na
na
133
EXHIBIT 2—ESTIMATED ANNUALIZED TOTAL COST BURDEN’>
Number of
respondents
Type of data collection
Total burden
hours
Average hourly
wage rate
Total cost burden
50
50
100
200
25
25
50
33
$83.59
14.31
21.35
83.59
$2,090
358
1,068
2,758
Total ..........................................................................................
mstockstill on DSK4VPTVN1PROD with NOTICES
Interviews with Clinicians .................................................................
Interviews with Support Staff ...........................................................
Interviews with Patients ...................................................................
Survey of Clinicians .........................................................................
400
133
na
6,274
Based upon the mean wages for clinicians (29–1062 family and general practitioners), clinical team members (31–9092 medical assistants)
and patients/consumers (00–0000 all occupations), National Compensation Survey: Occupational wages in the United States May 2010, ‘‘U.S.
Department of Labor, Bureau of Labor Statistics.’’
VerDate Mar<15>2010
17:14 Jan 25, 2012
Jkt 226001
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
E:\FR\FM\26JAN1.SGM
26JAN1
Federal Register / Vol. 77, No. 17 / Thursday, January 26, 2012 / Notices
Estimated Annual Costs to the Federal
Government
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
The maximum cost to the Federal
Government is estimated to be $217,451
annually for two years.
Exhibit 3 shows the total and
annualized cost by the major cost
components.
Agency for Healthcare Research and
Quality
EXHIBIT 3—ESTIMATED TOTAL AND
ANNUALIZED COST
Cost component
Total cost
Annualized
cost
Scientific Information Request on the
Use of Natriuretic Peptide
Measurement in the Management of
Heart Failure
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Request for scientific
information submissions.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ) is seeking
scientific information submissions from
medical device manufacturers of
natriuretic peptide measurement assays.
Scientific information is being solicited
to inform our Comparative Effectiveness
Review of Use of Natriuretic Peptide
Measurement in the Management of
Heart Failure, which is currently being
conducted by the Evidence-based
Practice Centers for the AHRQ Effective
Health Care Program. Access to
published and unpublished pertinent
scientific information on this device
will improve the quality of this
comparative effectiveness review.
AHRQ is requesting this scientific
information and conducting this
comparative effectiveness review
pursuant to Section 1013 of the
Medicare Prescription Drug,
Improvement, and Modernization Act of
2003, Public Law 108–173.
DATES: Submission Deadline on or
before February 27, 2012.
ADDRESSES: Online submissions: https://
effectivehealthcare.AHRQ.gov/
index.cfm/submit-scientificinformation-packets/. Please select the
study for which you are submitting
information from the list of current
studies and complete the form to upload
your documents.
Email submissions: ehcsrc@ohsu.edu
(please do not send zipped files—they
are automatically deleted for security
reasons).
Print submissions: Robin Paynter,
Oregon Health and Science University,
Oregon Evidence-based Practice Center,
3181 SW. Sam Jackson Park Road, Mail
Code: BICC, Portland, OR 97239–3098.
FOR FURTHER INFORMATION CONTACT:
Robin Paynter, Research Librarian,
Telephone: (503) 494–0147 or Email:
ehcsrc@ohsu.edu.
SUMMARY:
Project Development ..................
Data Collection Activities ................
Data Processing
and Analysis ......
Project Management ..................
Overhead ..............
Total ...............
$153,750
$76,875
162,465
81,233
33,563
16,781
22,625
62,500
11,313
31,250
434,903
217,451
Request for Comments
mstockstill on DSK4VPTVN1PROD with NOTICES
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ healthcare
research and healthcare information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: January 17, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012–1398 Filed 1–25–12; 8:45 am]
BILLING CODE 4160–90–M
VerDate Mar<15>2010
17:14 Jan 25, 2012
Jkt 226001
In
accordance with Section 1013 of the
Medicare Prescription Drug,
Improvement, and Modernization Act of
2003, Public Law 108–173, the Agency
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
4043
for Healthcare Research and Quality has
commissioned the Effective Health Care
(EHC) Program Evidence-based Practice
Centers to complete a comparative
effectiveness review of the evidence for
use of natriuretic peptide measurement
in the management of heart failure.
The EHC Program is dedicated to
identifying as many studies as possible
that are relevant to the questions for
each of its reviews. In order to do so, we
are supplementing the usual manual
and electronic database searches of the
literature by systematically requesting
information (e.g., details of studies
conducted) from medical device
industry stakeholders through public
information requests, including via the
Federal Register and direct postal and/
or online solicitations. We are looking
for studies that report on natriuretic
peptide measurement assays, including
those that describe adverse events, as
specified in the key questions detailed
below. The entire research protocol,
including the key questions, is also
available online at: https://
effectivehealthcare.ahrq.gov/index.cfm/
search-for-guides-reviews-and-reports/
?pageaction=displayproduct&
productid=899#4210.
This notice is a request for industry
stakeholders to submit the following:
• A current product label, if
applicable (preferably an electronic PDF
file).
• Information identifying published
randomized controlled trials and
observational studies relevant to the
clinical outcomes. Please provide both a
list of citations and reprints if possible.
• Information identifying
unpublished randomized controlled
trials and observational studies relevant
to the clinical outcomes. If possible,
please provide a summary that includes
the following elements: Study number,
study period, design, methodology,
indication and diagnosis, proper use
instructions, inclusion and exclusion
criteria, primary and secondary
outcomes, baseline characteristics,
number of patients screened/eligible/
enrolled/lost to withdrawn/follow-up/
analyzed, and effectiveness/efficacy and
safety results.
• Registered ClinicalTrials.gov
studies. Please provide a list including
the ClinicalTrials.gov identifier,
condition, and intervention.
Your contribution is very beneficial to
this program. AHRQ is not requesting
and will not consider marketing
material, health economics information,
or information on other indications.
This is a voluntary request for
information, and all costs for complying
with this request must be borne by the
submitter. In addition to your scientific
E:\FR\FM\26JAN1.SGM
26JAN1
]]>Agencies
[Federal Register Volume 77, Number 17 (Thursday, January 26, 2012)]
[Notices]
[Pages 4041-4043]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-1398]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the intention of the Agency for
Healthcare Research and Quality (AHRQ) to request that the Office of
Management and Budget (OMB) approve the proposed information collection
project: ``Assessing the Feasibility of Disseminating Effective Health
Care Products through a Shared Electronic Medical Record Serving Member
Organization of a Health Information Exchange.'' In accordance with the
Paperwork Reduction Act, 44 U.S.C. 3501-3521, AHRQ invites the public
to comment on this proposed information collection.
This proposed information collection was previously published in
the Federal Register on November 15th, 2011 and allowed 60 days for
public comment. No comments were received. The purpose of this notice
is to allow an additional 30 days for public comment.
DATES: Comments on this notice must be received by February 27, 2012.
ADDRESSES: Written comments should be submitted to: AHRQ's OMB Desk
Officer by fax at (202) 395-6974 (attention: AHRQ's desk officer) or by
email at OIRA_submission@omb.eop.gov (attention: AHRQ's desk officer).
Copies of the proposed collection plans, data collection
instruments, and specific details on the estimated burden can be
obtained from the AHRQ Reports Clearance Officer.
FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427-1477, or by email at
doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project
Assessing the Feasibility of Disseminating Effective Health Care
Products through a Shared Electronic Medical Record Serving Member
Organization of a Health Information Exchange
The Agency for Healthcare Research and Quality (AHRQ) requests that
the Office of Management and Budget (OMB) approve under the Paperwork
Reduction Act of 1995 this collection of information from users of work
products and services initiated by the John M. Eisenberg Clinical
Decisions and Communications Science Center (Eisenberg Center).
AHRQ is the lead agency charged with supporting research designed
to improve the quality of healthcare, reduce its cost, improve patient
safety, decrease medical errors, and broaden access to essential
services. AHRQ's Eisenberg Center's mission is improving communication
of findings to a variety of audiences (``customers''), including
consumers, clinicians, and health care policy makers. The Eisenberg
Center compiles research results into useful formats for customer
stakeholders. The Eisenberg Center also conducts investigations into
effective communication of research findings in order to improve the
usability and rapid incorporation of findings into medical practice.
The Eisenberg Center is one of three components of AHRQ's Effective
Health Care (EHC) Program. The collections proposed under this
clearance include activities to assess the feasibility of disseminating
materials developed by the Eisenberg Center through the use of an
electronic medical record (EMR) shared by a network of clinical care
providers that are part of a Health Information Exchange (HIE)
operating in multiple sites in several states. Our Community Health
Information Network (OCHIN) members include 30 clinical care
organizations operating more than 230 primary care clinics in six
states. Data will be gathered from three different OCHIN-member
organizations representing a total of 10 primary care clinics. The
information generated will be provided to AHRQ to guide decision making
and planning for additional efforts to foster EHC Program product
distribution via EMR prompting and product linkages.
This research has the following goals:
(1) Identify facilitators and barriers to successful efforts to
implement processes that: (a) Support use of EHC Program products by
clinicians in practice, and (b) place relevant clinical information in
the hands of patients and family members in languages and formats that
are appropriate to patients' information needs;
(2) Examine ways in which EHC Program products can be used in
concert with other support programs and products (e.g., healthwise[reg]
resources available through the EMR; brief patient instructions and
letters, including those designed for use with persons having very low
literacy skills);
(3) Assess the extent to which EHC Program products are used (e.g.,
accessed by clinicians, provided to patients in relevant formats) in
settings where use is supported by automated EMR features, such as on-
screen prompts and reminders; and
(4) Document the perceived value of integrating EHC Program
products into systems of care supported by an EMR system as self-
reported by clinicians involved in direct care of patients and clinic
support personnel who interact with patients.
This study is being conducted by AHRQ through its contractor, the
Eisenberg Center--Baylor College of Medicine, pursuant to AHRQ's
statutory authority to conduct and support research, and disseminate
information, on healthcare and on systems for the delivery of such
care, including activities with respect to the quality, effectiveness,
efficiency, appropriateness and value of healthcare services and
clinical practice. 42 U.S.C. 299a(a)(1) and (4).
Method of Collection
To achieve the goals of this project the following data collections
will be implemented:
(1) Automated Data Capture from EMR Usage Logs. Electronic usage
data will be collected to determine the extent to which EHC Program
guides for clinicians and patients were accessed to support shared
decision making and patient education. The data will be retrieved from
the existing EMR-linked database operated by the Kaiser Permanente
staff in their coordination of activities related to the OCHIN HIE.
Data will include: (a) Number and frequency of retrieval of EHC
resource materials; (b) specific types of materials retrieved; and (c)
health topic or condition targeted in the EHC materials. These data
will inform the development of follow-up questions to be administered
to clinicians and patients in the interviews and surveys described
below. Because the data will be obtained using automated systems
already in place, no special effort will be needed to generate these
data, and thus this task is not included in the burden estimates in
Exhibits 1 and 2.
[[Page 4042]]
(2) Interviews with Clinicians. Interviews will be held with
clinical service providers for the following purposes: (a) Obtain
perceptions of the overall value, relevancy, currency and
appropriateness of EHC Program products in addressing the health
service needs of patients treated in clinical settings; (b) assess ease
of use of the materials in terms of access via the EMR; (c) determine
perceived success of efforts to employ EHC Program products and related
materials in addressing the needs of patients with limited language
skills and/or low literacy levels; and (d) describe the relative
success of efforts to use the EHC Program products in concert with
other tools (e.g., healthwise[supreg] resources) in promoting patient
engagement in their own health care or in the care of family members.
(3) Interviews with Support Staff. Interviews will be held with
non-clinical support staff to characterize perceptions of how the
introduction of EHC Program products: (a) Affected clinic workflows and
influenced the work that staff was required to do in supporting
clinician-patient interactions; and (b) facilitated or impeded efforts
to inform patients about actions they could take in being more fully
involved in their own health care.
(4) Interviews with Patients. Interviews will be held with
recruited patients to determine if they: (a) Viewed the EHC Program
products that they were provided as useful to them in understanding
their health issues; (b) were able to understand the EHC Program-
related information that was provided to them sufficiently to take
actions in their own health care; and (c) have suggestions about how
the EHC Program materials could be changed or the delivery of them done
in a different way to make the materials more useful and/or accessible
to patients.
(5) Survey of Clinicians. A questionnaire will be administered to
clinical care providers near the end of the study to gather
quantitative data around their assessments of: (a) The relevancy of the
EHC Program materials to the patients they serve; (b) the
appropriateness of the products in addressing specific clinical issues;
(c) the ease of use of the system created to provide access to EHC
Program products through the EMR; and (d) overall ratings of the
approach in addressing patient needs with regard to specific conditions
addressed by the products available.
The interviews with clinicians, clinical staff, and patients will
be conducted throughout the project period, approximately every three
months with different sets of participants, to inform and refine
delivery mechanisms and monitor progress.
This information will be used to determine the feasibility of: (a)
Mounting broader efforts to distribute clinician and consumer guides,
as well as other EHC products using EMRs as the primary vehicle for
providing product access at the point of care; and (b) initiating
additional studies to identify factors that encourage or deter
effective integration of EHC products into care processes using
electronic tools and care delivery support systems, like the EMR, that
are increasingly common in clinical work settings.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated annualized burden for the
respondents' time to participate in this research. Three rounds of
interviews will be conducted during the project period (each round of
interviews to be held approximately every three months with separate
sets of participants) to assess progress and adjust methods or refine
materials as needed. Interviews will be conducted with 100 patients, 50
clinicians and 50 clinical support staff. Each interview is estimated
to last no more than 30 minutes. All clinicians in each participating
clinic will have access to the EMR and will be invited to participate
in an online questionnaire. Approximately 200 clinicians will complete
the 10-minute questionnaire.
Exhibit 2 shows the estimated annualized cost burden associated
with the respondents' time to participate in this research. The total
annual cost burden is estimated to be $6,274.
Exhibit 1--Estimated Annualized Total Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Type of data collection Number of responses per Hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
Interviews with Clinicians.............. 50 1 30/60 25
Interviews with Support Staff........... 50 1 30/60 25
Interviews with Patients................ 100 1 30/60 50
Survey of Clinicians.................... 200 1 10/60 33
-----------------------------------------------------------------------
Total............................... 400 na na 133
----------------------------------------------------------------------------------------------------------------
Exhibit 2--Estimated Annualized Total Cost Burden'>
----------------------------------------------------------------------------------------------------------------
Number of Total burden Average hourly Total cost
Type of data collection respondents hours wage rate burden
----------------------------------------------------------------------------------------------------------------
Interviews with Clinicians.............. 50 25 $83.59 $2,090
Interviews with Support Staff........... 50 25 14.31 358
Interviews with Patients................ 100 50 21.35 1,068
Survey of Clinicians.................... 200 33 83.59 2,758
-----------------------------------------------------------------------
Total............................... 400 133 na 6,274
----------------------------------------------------------------------------------------------------------------
Based upon the mean wages for clinicians (29-1062 family and general practitioners), clinical team members (31-
9092 medical assistants) and patients/consumers (00-0000 all occupations), National Compensation Survey:
Occupational wages in the United States May 2010, ``U.S. Department of Labor, Bureau of Labor Statistics.''
[[Page 4043]]
Estimated Annual Costs to the Federal Government
The maximum cost to the Federal Government is estimated to be
$217,451 annually for two years.
Exhibit 3 shows the total and annualized cost by the major cost
components.
Exhibit 3--Estimated Total and Annualized Cost
------------------------------------------------------------------------
Total Annualized
Cost component cost cost
------------------------------------------------------------------------
Project Development............................. $153,750 $76,875
Data Collection Activities...................... 162,465 81,233
Data Processing and Analysis.................... 33,563 16,781
Project Management.............................. 22,625 11,313
Overhead........................................ 62,500 31,250
-----------------------
Total....................................... 434,903 217,451
------------------------------------------------------------------------
Request for Comments
In accordance with the Paperwork Reduction Act, comments on AHRQ's
information collection are requested with regard to any of the
following: (a) Whether the proposed collection of information is
necessary for the proper performance of AHRQ healthcare research and
healthcare information dissemination functions, including whether the
information will have practical utility; (b) the accuracy of AHRQ's
estimate of burden (including hours and costs) of the proposed
collection(s) of information; (c) ways to enhance the quality, utility,
and clarity of the information to be collected; and (d) ways to
minimize the burden of the collection of information upon the
respondents, including the use of automated collection techniques or
other forms of information technology.
Comments submitted in response to this notice will be summarized
and included in the Agency's subsequent request for OMB approval of the
proposed information collection. All comments will become a matter of
public record.
Dated: January 17, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012-1398 Filed 1-25-12; 8:45 am]
BILLING CODE 4160-90-M
